Vontobel Holding’s ResMed RMD Stock Holding History

Vontobel Holding’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-900	Closed	-$232K	–	1418
2025 Q2	$232K	Buy	+900	New	+$215K	﹤0.01%	1128

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vontobel Holding's RMD Position: Q1 2026 in Review

Vontobel Holding reduced its ResMed (RMD) stake by 0.54% in Q1 2026, selling an estimated $7.23K and leaving 5,342 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #620.

Vontobel Holding first reported a position in RMD in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.63M in Q2 2023. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Vontobel Holding held 5,342 shares of ResMed worth $1.2M as of Q1 2026.
Vontobel Holding sold 29 ResMed shares in Q1 2026, an estimated $7.23K.
ResMed made up ﹤0.01% of Vontobel Holding's portfolio in Q1 2026, its #620 holding.
Vontobel Holding first reported a position in ResMed in Q4 2020 and has held it in 22 quarters since.
Vontobel Holding's ResMed position peaked at $3.63M in Q2 2023.
939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.